|
|
AlT3 |
|
Vaxjo ID |
121 |
|
Vaccine Adjuvant Name |
AlT3 |
|
Adjuvant VO ID |
VO_0005300
|
|
Description |
combination adjuvant with TLR3 receptor that induces Th1/Th2 response |
|
Stage of Development |
Research |
|
Location Licensed |
PAI Life Sciences in Seattle, WA |
|
Host Species for Testing |
Mouse |
|
Storage |
At least 3 months at 2-8 degrees C |
|
Function |
Type: combination vaccine adjuvant. Target Receptor: Toll-like receptor 3 (TLR3). Induces Th1/Th2 mixed immune profile. TLR3 agonist plus potential inflammasome |
| References |
(Carter, 2021): Vaccine Adjuvant Compendium (VAC) [https://vac.niaid.nih.gov/view?id=21]
|
|
